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Introduction: Hepatosplenic gamma delta T-cell lymphoma is a rare peripheral T-cell lymphoma of cytotoxic T-cell
origin with an aggressive clinical course. Chronic immunosuppression has been proposed as a possible
pathogenetic mechanism. No association of hepatosplenic gamma delta T-cell lymphoma with visceral leishmaniasis
has been described in the past. We describe a case of an adolescent boy with hepatosplenic gamma delta T-cell
lymphoma with leukemic presentation, who was diagnosed to have visceral leishmaniasis, 9 months prior to
presentation at our center. To the best of our knowledge this is the first report of hepatosplenic gamma delta T-cell
lymphoma with a prior history of visceral leishmaniasis in the medical literature.
Case presentation: A 13-year-old Indian boy presented to the hematology out-patient department with a history
of progressive abdominal distension of 9 months’ duration and low grade fever of 2 months’ duration. He was a
known case of visceral leishmaniasis and was treated with some clinical improvement in the past. However, his
symptoms recurred and he was diagnosed to have hepatosplenic gamma delta T-cell lymphoma at our center.
Cytogenetic analysis showed characteristic karyotype of isochromosome 7.
Conclusions: Chronic antigen stimulation due to visceral leishmaniasis may have led to an expansion of gamma
delta T cells in our patient, and immunophenotypic analysis of bone marrow aspirate and characteristic karyotype
helped to achieve the diagnosis. The aim of this case report is to highlight the rare association of hepatosplenic
T-cell lymphoma with visceral leishmaniasis.
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Gamma delta (γδ) T cells constitute 1% to 5% of the circu-
lating lymphocytes in human blood [1]. These cells prefer-
entially home in on some epithelial rich tissues and
sinusoidal areas of the splenic red pulp where they repre-
sent up to 30% of the whole T-cell population. Hepatosple-
nic γδ T-cell lymphoma (HSTCL) is a rare aggressive
subtype of extranodal lymphoma, representing less than 5%
of all peripheral T-cell lymphomas. It often affects young
males with a median age of onset of approximately 35 years
[1,2]. Approximately 150 cases have been described in the
literature since the initial description of this disease in 1990
[3]. The etiology of the disease is unknown, however, asso-
ciation with chronic immunosuppression including solid
organ transplantation, hematopoietic neoplasms, inflamma-
tory bowel disease, and malaria infection has been* Correspondence: harappati@yahoo.co.in
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reproduction in any medium, provided the ordescribed [4]. Lymphomas of B-cell lineage have earlier
been described in association with visceral leishmaniasis
(VL) [5,6]. Also association of VL with hepatosplenic T-cell
lymphoma has been reported in a canine in the past [7].
However, there has been no description of any T-cell
lymphoma associated with VL in humans. We describe the
rare association of HSTCL in a young adolescent male with
a prior history of VL, the first report of this kind to date.
Case presentation
A 13-year-old Indian boy, resident of Bihar, India, presented
to the hematology out-patient department with a history of
progressive abdominal distension of 9 months’ duration
and low grade fever of 2 months’ duration. He complained
of associated weakness, fatigue and weight loss. There was
no history of jaundice or enlarged lymph nodes. Evaluation
at another center at presentation had shown amastigote
forms of Leishmania in his bone marrow (BM) for which
he was treated with liposomal amphotericin B 0.6mg/kg forl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Peripheral blood smear showing large atypical
lymphoid cells with indented nuclei. Jenner Giemsa, ×400.
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months after the end of treatment, he presented with recur-
rence of fever and anemia. A repeat aspiration done at this
stage showed no Leishman-Donovan (LD) bodies, however,
30% blast-like cells were encountered. With a clinical suspi-
cion of hematolymphoid malignancy, he was referred to
our center.
Examination at our center revealed a thin boy with pallor
and petechial rash over his chest. No enlarged lymph nodes
were palpated. An abdominal examination revealed dis-
tended abdomen with multiple dilated veins. His liver was
enlarged 10cm and his spleen was enlarged 20cm belowFigure 2 A: Bone marrow biopsy showing cellular marrow with diffus
Giemsa, ×100); B: Arrows indicating intrasinusoidal lymphoid cell infithe costal margin extending up to his right iliac fossa. A
computed tomography scan of his abdomen showed
massive hepatosplenomegaly with prominence of portal
vein and mild ascites. No enlarged mediastinal or retroperi-
toneal lymph nodes were identified.
Investigations revealed hemoglobin of 76g/L, white blood
cell count of 17.28×109/L with 76% atypical medium to
large-sized lymphocytes seen on peripheral blood smears
(Figure 1), a platelet count of 40×109/L, and elevated lactate
dehydrogenase of 1024IU/L. Viral serology for hepatitis B,
C and human immunodeficiency virus 1 and 2 was normal.
A direct Coombs test was negative. A BM examination
repeated at our center showed normoblastic erythroid
precursors, normal myelogram and inadequate megakaryo-
cytes. A predominant population (50%) of atypical large-
sized lymphoid cells with oval to indented nuclei was seen.
No LD bodies were demonstrated. Immunophenotyping of
gated lymphoid cells on marrow cell suspension showed
CD3+, CD2+, CD7+, CD56+, T-cell receptor (TCR) γδ+,
TCR αβ–, and CD4– CD8–. Negativity for B cell markers
(CD19, CD10, CD22, CD79a); myelomonocytic markers
(myeloperoxidase, CD64, CD117) and immaturity markers
(CD34, human leukocyte antigen-DR, terminal deoxynu-
cleotidyl transferase) were seen. A BM biopsy showed
monomorphic intrasinusoidal and interstitial infiltration
of neoplastic lymphocytes (Figure 2A, 2B), which were
highlighted by T-lineage markers on immunohistochemis-
try. Previous BM smears were reviewed and showed no
atypical lymphoid cells. In view of the immunophenotype, a
diagnosis of HSTCL in a background of VL was established.
Cytogenetic evaluation on BM sample showed 45, X,–Y,i(7)
(q10). The patient, however, had an episode of massivee intrasinusoidal and interstitial lymphoid cell infiltrates (Jenner
ltrate (Jenner Giemsa, ×400).
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started on chemotherapy. An autopsy was not performed.
Discussion
HSTCL is characterized by significant hepatosplenomegaly,
without lymphadenopathy. BM examination combined with
immunophenotyping is sufficient for diagnosis, and splen-
ectomy is unwarranted [2]. Chronic immunosuppression
has been proposed as a possible pathogenetic mechanism
in HSTCL [2,5].
An association between hematolymphoid malig-
nancies and VL has been described rarely [5,6].
Leishmaniasis is caused by flagellated protozoa of the
genus Leishmania and is transmitted to humans by
the bite of a sand fly vector. VL is a systemic disease
with gradual onset of fever, pancytopenia, hepatosple-
nomegaly, and weight loss. The incubation period
can range from weeks to a year. VL is fatal if left
untreated [6]. Here, we report a case of HSTCL that
developed several months after VL infection. Bihar,
our patient’s native state, is an endemic area for VL
leishmaniasis in India. This raises the suspicion of a
possible correlation between HSTCL and VL, and
may represent different stages of clonal selection and
propagation, in the context of a chronic lymphoprolif-
erative process. The recognition of LD bodies in the
BM several months before the immunophenotypically
confirmed diagnosis of HSTCL is more likely to re-
flect chronic VL than a pre-existing HSTCL, which
was unrecognized and untreated in the past.
Other infections that have been described associated
with HSTCL are falciparum malaria and Epstein–Barr
virus infections [2]. Of interest, both of these infections
and VL have been associated with the expansion of T
cells, presumably as a result of chronic antigenic stimu-
lation. It is possible that γδ T cells are involved in the
host response to Leishmania parasite, and prolonged
antigenic stimulation and chronic immunosuppression,
typical of VL, may play a role in the pathogenesis of
HSTCL. In view of the characteristic cytogenetic abnor-
mality of isochromosome 7, there still remains a possi-
bility that the association of VL with HSTCL may be a
chance occurrence. Nevertheless, the association with
VL cannot be ignored and has been described to occur
in a dog in the past [7].
Our patient had a leukemic presentation with 70%
blast-like cells in the peripheral blood. This is more
frequently seen during the late stages of this disease
or after splenectomy. BM infiltration usually in
HSTCL is also seen in the later stages of the disease,
and the need for repeated BM biopsy has been indi-
cated [8]. Different patterns of involvement have
been reported, including exclusively sinusoidal, inter-
stitial, and mixed sinusoidal and interstitial [9].Immunophenotypic analysis of BM helps to clinch
the diagnosis because it is helpful for demonstration
of aberrant T-cell lineage. In our patient, the initial
BM and biopsy specimen were negative morpho-
logically and immunophenotypic analysis on BM was
not performed.
Conclusion
In conclusion, chronic antigen stimulation due to VL
may have led to the expansion of γδ T cells in our
patient and immunophenotypic analysis of BM and
characteristic karyotype helped to achieve the diag-
nosis of HSTCL.
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